Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes

Charlotte Andersson; Stig Lyngbæk; Cu Dinh Nguyen; Mia Nielsen; Gunnar H Gislason; Lars Køber; Christian Torp-Pedersen

doi:10.1001/2012.jama.10779

Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes

Charlotte Andersson, Stig Lyngbæk, Cu Dinh Nguyen, Mia Nielsen, Gunnar H Gislason, Lars Køber, Christian Torp-Pedersen

Research output: Contribution to journal › Journal article › Research › peer-review

44 Citations (Scopus)

Abstract

Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.

Original language	English
Journal	J A M A: The Journal of the American Medical Association
Volume	308
Issue number	9
Pages (from-to)	882-9
Number of pages	8
ISSN	0098-7484
DOIs	https://doi.org/10.1001/2012.jama.10779
Publication status	Published - 2012

Access to Document

10.1001/2012.jama.10779

Cite this

Andersson, C., Lyngbæk, S., Nguyen, C. D., Nielsen, M., Gislason, G. H., Køber, L., & Torp-Pedersen, C. (2012). Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. J A M A: The Journal of the American Medical Association, 308(9), 882-9. https://doi.org/10.1001/2012.jama.10779

Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. / Andersson, Charlotte; Lyngbæk, Stig; Nguyen, Cu Dinh; Nielsen, Mia; Gislason, Gunnar H ; Køber, Lars ; Torp-Pedersen, Christian.

In: J A M A: The Journal of the American Medical Association, Vol. 308, No. 9, 2012, p. 882-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Andersson, C, Lyngbæk, S, Nguyen, CD, Nielsen, M, Gislason, GH , Køber, L & Torp-Pedersen, C 2012, 'Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes', J A M A: The Journal of the American Medical Association, vol. 308, no. 9, pp. 882-9. https://doi.org/10.1001/2012.jama.10779

Andersson, Charlotte ; Lyngbæk, Stig ; Nguyen, Cu Dinh ; Nielsen, Mia ; Gislason, Gunnar H ; Køber, Lars ; Torp-Pedersen, Christian. / Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. In: J A M A: The Journal of the American Medical Association. 2012 ; Vol. 308, No. 9. pp. 882-9.

@article{0ee1b200204448e8bbf7bd7356a7ef4d,

title = "Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes",

abstract = "Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.",

author = "Charlotte Andersson and Stig Lyngb{\ae}k and Nguyen, {Cu Dinh} and Mia Nielsen and Gislason, {Gunnar H} and Lars K{\o}ber and Christian Torp-Pedersen",

year = "2012",

doi = "10.1001/2012.jama.10779",

language = "English",

volume = "308",

pages = "882--9",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes

AU - Andersson, Charlotte

AU - Lyngbæk, Stig

AU - Nguyen, Cu Dinh

AU - Nielsen, Mia

AU - Gislason, Gunnar H

AU - Køber, Lars

AU - Torp-Pedersen, Christian

PY - 2012

Y1 - 2012

N2 - Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.

AB - Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.

U2 - 10.1001/2012.jama.10779

DO - 10.1001/2012.jama.10779

M3 - Journal article

C2 - 22948698

VL - 308

SP - 882

EP - 889

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 9

ER -